Exane Derivatives’s Alibaba BABA Stock Holding History

Exane Derivatives’s Portfolio BABA Stock Details BABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.07M	Sell	9,429 -1,082	-10%	-$106K	0.62%	37
2022 Q1	$1.14M	Sell	10,511 -4,016	-28%	-$463K	0.32%	74
2021 Q4	$1.73M	Sell	14,527 -1,794	-11%	-$261K	0.42%	46
2021 Q3	$2.42M	Buy	16,321 +4,396	+37%	+$800K	0.58%	30
2021 Q2	$2.5M	Buy	11,925 +1,103	+10%	+$245K	0.57%	30
2021 Q1	$2.45M	Buy	10,822 +5,276	+95%	+$1.3M	0.7%	32
2020 Q4	$1.29M	Buy	5,546 +1,590	+40%	+$441K	0.38%	54
2020 Q3	$1.16M	Sell	3,956 -19,753	-83%	-$5.2M	0.34%	65
2020 Q2	$5.11M	Sell	23,709 -2,929	-11%	-$610K	1.37%	15
2020 Q1	$5.18M	Buy	26,638 +16,403	+160%	+$3.42M	1.45%	15
2019 Q4	$2.3M	Sell	10,235 -2,069	-17%	-$388K	0.43%	75
2019 Q3	$2.06M	Buy	+12,304	New	+$2.11M	0.37%	69
2019 Q1	–	Sell	-560	Closed	-$76.7K	–	668
2018 Q4	$76.7K	Sell	560 -9,400	-94%	-$1.39M	0.01%	341
2018 Q3	$1.64M	Buy	9,960 +3,401	+52%	+$602K	0.31%	81
2018 Q2	$1.22M	Buy	6,559 +1,160	+21%	+$221K	0.2%	106
2018 Q1	$966K	Sell	5,399 -1,280	-19%	-$241K	0.19%	122
2017 Q4	$1.15M	Buy	6,679 +1,564	+31%	+$280K	0.2%	94
2017 Q3	$883K	Buy	+5,115	New	+$829K	0.17%	91
2017 Q1	–	Sell	-5,890	Closed	-$517K	–	579
2016 Q4	$517K	Buy	5,890 +2,757	+88%	+$265K	0.1%	152
2016 Q3	$331K	Sell	3,133 -14,291	-82%	-$1.32M	0.05%	175
2016 Q2	$1.39M	Buy	17,424 +11,642	+201%	+$911K	0.23%	66
2016 Q1	$457K	Buy	+5,782	New	+$407K	0.06%	140
2015 Q2	–	Sell	-7,350	Closed	-$632K	–	525
2015 Q1	$612K	Buy	7,350 +4,850	+194%	+$438K	0.07%	126
2014 Q4	$260K	Buy	+2,500	New	+$257K	0.04%	190

Other funds holding BABA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Exane Derivatives's BABA Position: Q2 2022 in Review

Exane Derivatives reduced its Alibaba (BABA) stake by 10% in Q2 2022, selling an estimated $106K and leaving 9,429 shares worth $1.07M. The position accounts for 0.62% of the portfolio, ranked #37.

Exane Derivatives first reported a position in BABA in Q4 2014 and has held it in 24 quarters since. The position peaked at $5.18M in Q1 2020. 1,304 funds tracked by Wall St. Rank hold BABA as of Q2 2022.

Exane Derivatives held 9,429 shares of Alibaba worth $1.07M as of Q2 2022.
Exane Derivatives sold 1,082 Alibaba shares in Q2 2022, an estimated $106K.
Alibaba made up 0.62% of Exane Derivatives's portfolio in Q2 2022, its #37 holding.
Exane Derivatives first reported a position in Alibaba in Q4 2014 and has held it in 24 quarters since.
Exane Derivatives's Alibaba position peaked at $5.18M in Q1 2020.
1,304 funds tracked by Wall St. Rank held Alibaba as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.